Yasmin Meghdadi

Yasmin Meghdadi

Auto-generated profile, based on publicly available information

Yasmin Meghdadi

Faculty of Health Sciences, McMaster University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in Melanoma Management
Verified
Journal Article
Open access
AAAdil Amarsi
Adil Amarsi
JXJoy Xu
Joy Xu
JCJosh Chan
Josh Chan
YJYuan Chun Jiang
Yuan Chun Jiang
AOAhmad Zobair Omar
Ahmad Zobair Omar
AWAlyssa Wu
Alyssa Wu
Melanoma is one of the most fatal skin cancers, with rising incidence and mortality worldwide. From diagnosis to treatment, patient experiences often involve anxiety, symptom burden, and limited access to information which profoundly impacts health outcomes. This systematic review aims to identify and analyze major barriers melanoma patients face throughout their healthcare journey. Studies were identified from PubMed, Scopus, Web of Science, Embase, and Cochrane Library, supplemented by manual hand-searching. Eligible studies focused on the experiences of melanoma patients, addressed knowledge gaps and barriers to care throughout the patient journey, and were published in English between 2013 and 2023. Screening and extraction were conducted independently and in duplicate. The methodological quality of the included studies was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Out of 2,257 screened articles, 183 met the inclusion criteria. Studies were categorized into four major themes: intersectionality, treatment, diagnosis/prognosis, and patient/societal burden. Commonly explored subcategories included self-examination, risk factors, and drug efficacy. Melanoma patients experience significant gaps throughout their healthcare journey. Identifying areas of improvement in current practices is the first step toward developing targeted solutions that improve the patient experience and quality of life.

13 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
AAAdil Amarsi
Adil Amarsi
JCJosh Chan
Josh Chan
YJYuan Chun Jiang
Yuan Chun Jiang
AOAhmad Zobair Omar
Ahmad Zobair Omar
YMYasmin Meghdadi
Yasmin Meghdadi
JXJoy Xu
Joy Xu
Background Melanoma is one of the most fatal skin cancers, with rising incidence and mortality worldwide. From diagnosis to treatment, patient experiences often involve anxiety, symptom burden, and limited access to information which profoundly impacts the quality of overall patient outcomes. Objective This systematic review aims to identify and analyze major barriers melanoma patients face throughout their healthcare journey. Methods Per PRISMA guidelines, studies were identified from PubMed, Scopus, Web of Science, Embase, and Cochrane Library, supplemented by manual hand-searching. Eligible studies focused on the experiences of melanoma patients within Western healthcare systems, addressed knowledge gaps and barriers to care throughout the patient journey, and were published in English between 2013 and 2023. Screening and extraction were conducted independently and in duplicate. Findings were synthesized based on identified themes. The methodological quality of the included studies was assessed using the GRADE criteria. Results Out of 2,257 screened articles, 183 met the inclusion criteria. Studies were categorized into four major themes: intersectionality, treatment, diagnosis/prognosis, and patient/societal burden. Commonly explored subcategories included self-examination, risk factors, and drug efficacy. This focus was driven by the emergence of novel self-examination interventions and knowledge gaps regarding risk factors and prognosis, particularly in relation to newly introduced immune checkpoint inhibitors and targeted therapies. Conclusions Melanoma patients experience significant gaps throughout their healthcare journey. Identifying areas of improvement in current practices is the first step toward developing targeted solutions that improve the patient experience and quality of life.

1 July 2026 in Burns
Verified
Journal Article
Closed access
Noam GoderNoam Goder
Noam Goder
YMYasmin Meghdadi
Yasmin Meghdadi
MTMarshall Thibedeau
Marshall Thibedeau
ARAlan David Rogers
Alan David Rogers
DWDavid L. Wallace
David L. Wallace
SMStephanie A. Mason
Stephanie A. Mason